Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders

NCT03943537 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Psychosis
Schizophrenia
Schizo Affective Disorder
Bipolar I Disorder

Interventions

DRUG: Intranasal Insulin

Sponsor

Mclean Hospital